Current treatment of chronic beryllium disease

Journal of Occupational and Environmental Hygiene

Volumn 6, Issue 12, 2009, Pages 762-765

  Sood, Akshay ^a  

^a UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Beryllium; Chronic beryllium disease; Corticosteroids

Indexed keywords

AZATHIOPRINE; BERYLLIUM; BRONCHODILATING AGENT; CORTICOSTEROID; DIURETIC AGENT; INFLUENZA VACCINE; METHOTREXATE; PNEUMOCOCCUS VACCINE; PREDNISONE;

ADJUVANT THERAPY; BERYLLIOSIS; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; DRUG EFFECT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA; INFLUENZA VACCINATION; LUNG FIBROSIS; LUNG FUNCTION TEST; MORTALITY; OCCUPATIONAL EXPOSURE; OXYGEN THERAPY; PRIORITY JOURNAL; PULMONARY REHABILITATION; RECURRENT DISEASE; SHORT SURVEY; STREPTOCOCCUS PNEUMONIA;

ADRENAL CORTEX HORMONES; BERYLLIOSIS; HUMANS; OCCUPATIONAL EXPOSURE; PULMONARY FIBROSIS; RECURRENCE; RESPIRATORY FUNCTION TESTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 70449567037     PISSN: 15459624     EISSN: 15459632     Source Type: Journal    
DOI: 10.1080/15459620903158698     Document Type: Short Survey

References (29)

1. Kreiss, K., M.M. Mroz, L.S. Newman, J. Martyny, and B. Zhen: Machining risk of beryllium disease and sensitization with median exposures below 2 micrograms/m3. Am. J. Ind. Med. 30(1):16-25 (1996).
2. Kreiss, K., M.M. Mroz, B. Zhen, J.W. Martyny, and L.S. Newman: Epidemiology of beryllium sensitization and disease in nuclear workers. Am. Rev. Respir. Dis. 148(4 Pt 1):985-991 (1993).
3. Hardy, H.L., and I.R. Tabershaw: Delayed chemical pneumonitis occurring in workers exposed to beryllium compounds. J. Ind. Hyg. Toxicol. 28:197-211 (1946).
4. Mroz, M.M., K. Kreiss, D.C. Lezotte, P.A. Campbell, and L.S. Newman: Reexamination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease. J. Allergy Clin. Immunol. 88(1):54-60 (1991).
5. Newman, L.S., C. Bobka, B. Schumacher, et al.: Compartmentalized immune response reflects clinical severity of beryllium disease. Am. J. Respir. Crit. Care Med. 150(1):135-142 (1994).
6. Newman, L.S., K. Kreiss, T.E. King, Jr., S. Seay, and P.A. Campbell: Pathologic and immunologic alterations in early stages of beryllium disease. Re-examination of disease definition and natural history. Am. Rev. Respir. Dis. 139(6):1479-1486 (1989). (Pubitemid 19155510)
7. Richeldi, L.,R. Sorrentino, andC. Saltini: HLA-DPB1 glutamate 69:A genetic marker of beryllium disease. Science 262(5131):242-244 (1993).
8. Richeldi, L., K. Kreiss, M.M. Mroz, B. Zhen, P. Tartoni, and C. Saltini: Interaction of genetic and exposure factors in the prevalence of berylliosis. Am. J. Ind. Med. 32(4):337-340 (1997).
9. Wang, Z., P.S. White, M. Petrovic, et al.: Differential susceptibilities to chronic beryllium disease contributed by different Glu69 HLA-DPB1 and -DPA1 alleles. J. Immunol. 163(3):1647-1653 (1999).
10. National Research Council of the National Academies: Epidemiologic and clinical studies of beryllium sensitization and chronic beryllium disease. In Managing Health Effects of Beryllium Exposure.Washington, D.C.: The National Academies Press, 2008. pp. 52-84.
11. Newman, L.S., J. Lloyd, and E. Daniloff: The natural history of beryllium sensitization and chronic beryllium disease. Environ. Health Perspect. 104(Suppl 5):937-943 (1996).
12. Hardy, H.L.: The disability found in persons exposed to certain beryllium compounds. AMA Arch. Ind. Health 12(2):174-181 (1955).
13. Seeler, A.O.: Treatment of chronic beryllium poisoning. AMA Arch. Ind. Health 19(2):164-168 (1959).
14. Peyton, M.F., and J. Worcester: Exposure data and epidemiology of the beryllium case registry, 1958. AMA Arch. Ind. Health 19(2):94-99 (1959).
15. Stoeckle, J.D.,H.L.Hardy, and A.L.Weber: Chronic beryllium disease: Long-term follow-up of sixty cases and selective review of the literature. Am. J. Med. 46:545-561 (1969).
16. Ferris, B.G.: Pulmonary function in patients with beryllium intoxication. AMA Arch. Ind. Health 19:147-149 (1958).
17. Gaensler, E.A., J.M. Verstraeten, W.B. Weil, et al.: Respiratory pathophysiology in chronic beryllium disease. AMA Arch. Ind. Health 19(50):132-163 (1958).
18. De Nardi, J.M.: Long-term experience with beryllium disease. AMA Arch. Ind. Health 19:110-116 (1958).
19. Sprince, N.L., D.J. Kanarek, A.L. Weber, R.I. Chamberlin, and H. Kazemi: Reversible respiratory disease in beryllium workers. Am. Rev. Respir. Dis. 117(6):1011-1017 (1978).
20. Nishikawa, S., T. Hirata, M. Kitaichi, and T. Izumi: Three Years Prospective Study of Mantoux Reactions in Factory Workers Exposed to Beryllium Oxide. Cardiff, Wales: Alpha Omega Publishing, 1980.
21. Mapel, D., and D. Coultas: Disorders due to minerals other than silica, coal, and asbestos, and to metals. In Occupational Disorders of the Lung: Recognition, Management and Prevention, D.J. Hendrick, P.S. Burge, W.S. Beckett, and A. Churg (eds.). New York: W.B. Saunders, 2002.
22. Sood, A., W.S. Beckett, and M.R. Cullen: Variable response to long-term corticosteroid therapy in chronic beryllium disease. Chest 126(6):2000-2007 (2004).
23. Maier, L.A., C. Gunn, and L.S. Newman: Beryllium disease. In Environmental and Occupational Medicine, 4th edition, W.N. Rom and S. Markowitz (eds.). Philadelphia: LippincottWilliams &Wilkins, 2006. pp. 1021-1037.
24. Rossman,M.D.: Chronic beryllium disease: Diagnosis andmanagement. Environ. Health Perspect. 104(Suppl 5):945-947 (1996).
25. Alberts, W.M.: Lung disease and the lightest of metals. Chest 126(6):1730-1732 (2004).
26. Marchand-Adam, S., A. El Khatib, F. Guillon, et al.: Short- and longterm response to corticosteroid therapy in chronic beryllium disease. Eur. Respir. J. 32(3):687-693 (2008).
27. Glazer, C.S., and L.S. Newman: Chronic beryllium disease: Don't miss the diagnosis? J. Respir. Dis. 24(8):357-363 (2003).
28. Muller-Quernheim, J., K. Kienast, M. Held, S. Pfeifer, and U. Costabel: Treatment of chronic sarcoidosis with an azathioprine/prednisolone regimen. Eur. Respir. J. 14(5):1117-1122 (1999).
29. "Beryllium toxicity." [Online] Available at http://www.atsdr.cdc.gov/csem/beryllium/index.html (Accessed February 12, 2009).